课题基金 / 基金详情

NCI PHYSICIAN-INVESTIGATOR DEVELOPMENT AWARD PROGRAM

NCI PHYSICIAN-INVESTIGATOR DEVELOPMENT AWARD PROGRAM
NCI 医师-研究员发展奖励计划
批准号:
3079604
负责人:
Arnold S. Freedman
金额:
$5.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-08-01 至 1989-07-31

项目摘要

项目成果

Arnold S. Freedman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall aim of this project is the functional characterization of cell surface antigens expressed on activated but not resting human B lymphocytes. These antigens are excellent candidates for cell surface structures which control B cell activation, proliferation, and differentiation. This proposal will involve a detailed analysis of B cell activation antigens with specific attention to: 1) the stimuli which induce their expression, 2) their relationship to other B cell antigens expressed on both resting and activated B cells, 3) their relationship to growth and differentiation factors which are involved in the proliferation of B cells and stimulation of immunoglobulin secretion, and 4) the expression of these antigens on neoplastic B cells, and their possible role in neoplastic B cell proliferation. To accomplish this, monoclonal antibodies to previously known and new B cell activation antigens will be developed, and extensively characterized. The expression of these antigens will be related to the stages of B cell activation/proliferation and differentiation, and more importantly an attempt will be made to define the functional importance of these antigens. Finally, the expression of B cell activation antigens will be examined on B cell leukemias and lymphomas. This will be done in order to determine whether there is a correlation between antigen expression on neoplastic B cells and both the ability to respond to physiologic triggers of activation/proliferation in vitro as well as the clinical presentation and course of disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CpG Plus Rituximab Therapy in Follicular Lymphoma
  • 批准号:
    6792326
  • 项目类别:
  • 资助金额:
    $28.46万
  • 财政年份:
    2004
  • 负责人:
    Arnold S. Freedman
  • 依托单位:
CpG Plus Rituximab Therapy in Follicular Lymphoma
  • 批准号:
    6889316
  • 项目类别:
  • 资助金额:
    $28.27万
  • 财政年份:
    2004
  • 负责人:
    Arnold S. Freedman
  • 依托单位:
Etanercept Therapy in Follicular Lymphoma
  • 批准号:
    6585639
  • 项目类别:
  • 资助金额:
    $28.47万
  • 财政年份:
    2002
  • 负责人:
    Arnold S. Freedman
  • 依托单位:
Etanercept Therapy in Follicular Lymphoma
  • 批准号:
    6660312
  • 项目类别:
  • 资助金额:
    $28.46万
  • 财政年份:
    2002
  • 负责人:
    Arnold S. Freedman
  • 依托单位:
海外基金